Replimune Group

Replimune Group FCF Margin

Free Cash Flow Margin of Replimune Group (REPL) as of Oct 9, 2026.

FCF Margin

-

Last updated:

Free Cash Flow Margin of Replimune Group is 2026 - . Free Cash Flow Margin of Replimune Group was 2025 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Replimune Group Stock analysis

What does Replimune Group do? Replimune Group Inc is an American biotechnology company based in Woburn, Massachusetts. The company focuses on the development of therapeutics for cancer treatments through the application of oncolytic viruses. Replimune Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Replimune Group stock

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Replimune Group since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Replimune Group with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Replimune Group

All Key Metrics — Replimune Group